Cargando…
The effect of an interleukin receptor antagonist (IL-1ra) on colonocyte eicosanoid release
We investigated whether an interleukin 1 receptor antagonist (IL-1ra) altered cellular release of prostanoids and leukotrienes in a transformed colonic cell line (CACO-2) in the presence of proinflammatory stimuli. Cellular inflammation was induced by treatment with lipopolysaccharide (LPS) or the c...
Autores principales: | Smith, G. S., Rieckenberg, C., Longo, W. E., Kaminski, D. L., Mazuski, J. E., Deshpande, Y., Miller, T. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365825/ https://www.ncbi.nlm.nih.gov/pubmed/18475751 http://dx.doi.org/10.1155/S0962935196000622 |
Ejemplares similares
-
Effects of leflunomide on interleukin-1 receptor antagonist (IL-1Ra) synthesis in chondrocytes and synovial fibroblasts
por: Palmer, G, et al.
Publicado: (2003) -
The Experimental Treatment of Corneal Graft Rejection with the Interleukin-1 Receptor Antagonist (IL-1ra) Gene
por: Yuan, Jin, et al.
Publicado: (2013) -
Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by interleukin-1 receptor antagonist IL-1Ra
por: Ji, Daisy X., et al.
Publicado: (2019) -
Opium Addiction Increases Interleukin 1 Receptor Antagonist (IL-1Ra) in the Coronary Artery Disease Patients
por: Saadat, Habibollah, et al.
Publicado: (2012) -
IL-1 Receptor Antagonist (IL-1Ra) Levels and Management of Metabolic Disorders
por: Luotola, Kari
Publicado: (2022)